generics

FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose Treatment
FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose Treatment
RAPS.org
Teva Pharmaceutical
FDA
generics
Naloxone
Narcan
opioid overdose
Flag link:
United Therapeutics Fires Back After Sandoz Files Anti-Competitive Lawsuit Over PAH Drug
United Therapeutics Fires Back After Sandoz Files Anti-Competitive Lawsuit Over PAH Drug
BioSpace
United Therapeutics
PAH
Remodulin
generics
Sandoz
Flag link:
Akorn Inc. Scores Two Generic Approvals from the FDA
Akorn Inc. Scores Two Generic Approvals from the FDA
BioSpace
Akorn
FDA
generics
Flonase
GSK
Lotemax
Bausch + Lomb
Flag link:
Generics would get a new boost from bipartisan bills
Generics would get a new boost from bipartisan bills
BioCentury
Senate
generics
biosimilars
competition
legislation
Flag link:
Pfizer, AstraZeneca and J&J Take Issue With FDA’s List of Companies Withholding Drug Samples
Pfizer, AstraZeneca and J&J Take Issue With FDA’s List of Companies Withholding Drug Samples
RAPS.org
generics
Pfizer
AstraZeneca
JNJ
Flag link:
Wockhardt receives US FDA approval for cancer drug
Wockhardt receives US FDA approval for cancer drug
Pharmaceutical Business Review
Wockhardt
decitabine
FDA
generics
Otsuka
Dacogen
myelodysplastic syndromes
Flag link:
Gilead cuts cardiopulmonary sales reps
Gilead cuts cardiopulmonary sales reps
BioCentury
Gilead Sciences
layoffs
generics
Letairis
Ranexa
Flag link:
Manufacturing problems persist for Aurobindo, U.S.' second-largest generics producer
Manufacturing problems persist for Aurobindo, U.S.' second-largest generics producer
Fierce Pharma
Aurobindo
generics
Novartis
drug manufacturing
Flag link:
After Apotex founder's murder, family weighs sale worth up to $3B: report
After Apotex founder's murder, family weighs sale worth up to $3B: report
Fierce Pharma
Apotex
generics
Barry Sherman
M&A
Flag link:
AARP report offers window into generic drugmaker pain
AARP report offers window into generic drugmaker pain
Biopharma Dive
drug pricing
retail pricing
generics
AARP
Flag link:
Medicaid misclassification bill inspired by EpiPen snafu passes Congress
Medicaid misclassification bill inspired by EpiPen snafu passes Congress
Fierce Pharma
Mylan
generics
EpiPen
Medicaid
congress
misclassification
Flag link:
After Alzheimer’s collapse, Biogen must win Tecfidera patent challenge
After Alzheimer’s collapse, Biogen must win Tecfidera patent challenge
EP Vantage
Biogen
Alzheimer's disease
Tecfidera
generics
Mylan
Flag link:
Behind the Numbers: FDA Offers Budget Specifics, New Proposals
Behind the Numbers: FDA Offers Budget Specifics, New Proposals
RAPS.org
FDA
opioid crisis
generics
devices
Flag link:
FDA approves valsartan generic amid probe into impurities
FDA approves valsartan generic amid probe into impurities
Biopharma Dive
FDA
hypertension
generics
Valsartan
Flag link:
CEO of Novartis’ generics unit quits, sparking sale speculation
CEO of Novartis’ generics unit quits, sparking sale speculation
Pharmaforum
Novartis
Sandoz
generics
M&A
Richard Francis
biosimilars
Flag link:
Trump’s 2020 Budget Seeks FDA Tweaks to Increase Generic Competition
Trump’s 2020 Budget Seeks FDA Tweaks to Increase Generic Competition
RAPS.org
Donald Trump
competition
FDA
generics
Flag link:
Mylan's Advair generic pressures GSK with strong launch
Mylan's Advair generic pressures GSK with strong launch
BioPharma Dive
GSK
Mylan
generics
Advair
Wixela Inhub
Flag link:
Teva launches generic for Pfizer’s Flector pain patch
Teva launches generic for Pfizer’s Flector pain patch
Drug Delivery Business News
Teva Pharmaceutical
generics
Pfizer
Flector
pain patches
Flag link:
2018 in Generic Drugs: Approvals Shine but Questions Remain on Competition
2018 in Generic Drugs: Approvals Shine but Questions Remain on Competition
RAPS.org
generics
Flag link:
Additional exclusivity for a cancer treatment could cost the public $3 billion, analyst says
Additional exclusivity for a cancer treatment could cost the public $3 billion, analyst says
Endpoints
FDA
Eagle Pharmaceuticals
Treanda
generics
Flag link:

Pages